Disparities in Cisplatin-Induced Cytotoxicity—A Meta-Analysis of Selected Cancer Cell Lines

Cisplatin is a classic anticancer drug widely used as a reference drug to test new metal complex drug candidates. We found an unexpected diversity in cisplatin-related cytotoxicity values, expressed as IC(50) (the half-maximal inhibitory concentration) in tumour cell lines, such as MCF-7, HepG2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ćwiklińska-Jurkowska, Małgorzata, Wiese-Szadkowska, Małgorzata, Janciauskiene, Sabina, Paprocka, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421281/
https://www.ncbi.nlm.nih.gov/pubmed/37570731
http://dx.doi.org/10.3390/molecules28155761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421281/
https://www.ncbi.nlm.nih.gov/pubmed/37570731
http://dx.doi.org/10.3390/molecules28155761

Ejemplares similares